Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06927076
Recruiting
Antidepressant Response of DMT Masked With Propofol
Not applicable · Switzerland · 1 site
Registry update: 2 Apr 2026
NCT07118046
Recruiting
Comparison of Fluoroscopy-only vs. Electroanatomic Mapping Strategies for Pulmonary Vein Isolation With Balloon-based Pulsed-field Ablation
Not applicable · Spain · 1 site
Registry update: 11 Sept 2025
2024-514595-41-00
Recruiting
Study to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia
Phase 3 · Austria, Germany, Spain, France, Greece, Netherlands · 7 sites
Registry update: 26 Oct 2026
NCT07027488
Recruiting
AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 · United States · 1 site
Registry update: 16 Jun 2026
NCT07164846
Recruiting
Effect of Neuro20 Functional Electrical Stimulation Suit on Autonomic Function, Muscle Performance, and Gait
Not applicable · United States · 2 sites
Registry update: 19 Oct 2026
NCT07191899
Recruiting
To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension
Phase 1 · China · 1 site
Registry update: 25 Sept 2025
NCT07096973
Recruiting
Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery
Not applicable · Switzerland · 1 site
Registry update: 29 Sept 2026
NCT07144696
Recruiting
Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients
Not applicable · China · 1 site
Registry update: 4 Sept 2025
NCT07075016
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Phase 3 · Austria, Belgium, Switzerland, Germany, Denmark, Estonia, Spain, Finland, France, United Kingdom, Ireland, Italy, Lithuania, Netherlands, Norway, Sweden · 119 sites
Registry update: 19 Aug 2025
NCT07062965
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Phase 3 · Argentina, Australia, Belgium, Bulgaria, Brazil, Canada, China, Czechia, Germany, Spain, Finland, France, United Kingdom, Greece, Hungary, Israel, India, Italy, Japan, South Korea, Mexico, Netherlands, New Zealand, Poland, Puerto Rico, Sweden, Slovakia, Taiwan, United States, South Africa · 426 sites
Registry update: 19 Oct 2026
NCT07100119
Recruiting
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Phase 1 · Belgium, Canada, Germany, Spain, Netherlands · 12 sites
Registry update: 5 Nov 2026
NCT06869941
Recruiting
Adipose Tissue Gene Expression and Metabolomics Links to the Gut Microbiome-brain Axis
Not applicable · Spain · 1 site
Registry update: 31 Mar 2026
NCT06905405
Recruiting
The Use of Advanced Imaging in HFpEF
Not applicable · United Kingdom · 2 sites
Registry update: 18 Mar 2026
NCT07267819
Recruiting
Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
Not applicable · United States · 1 site
Registry update: 5 Dec 2025
2025-521462-96-00
Recruiting
A Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren’s Disease
Phase 1 · Germany, France, Italy, Poland · 13 sites
Registry update: 6 May 2026
NCT07481110
Recruiting
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
Not applicable · Algeria · 15 sites
Registry update: 27 Mar 2026
NCT06968390
Recruiting
Accelerated TMS for Perinatal Depression
Not applicable · United States · 1 site
Registry update: 18 Sept 2026
NCT06871228
Recruiting
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
Not applicable · China · 22 sites
Registry update: 4 Mar 2026
NCT06607458
Recruiting
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Phase 2 · Czechia, Germany, Spain, United Kingdom, Italy, Netherlands, Serbia, United States · 20 sites
Registry update: 20 Oct 2026
NCT07085975
Recruiting
The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges
Phase 1 · Canada · 1 site
Registry update: 29 Aug 2025

Ordered by registry start date. Freshness and sponsorship never change the order.